EAGLE PHARMACEUTICALS, INC. Quarterly Interest Expense in USD from Q1 2013 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2013 to Q2 2023.
  • Eagle Pharmaceuticals, Inc. Interest Expense for the quarter ending June 30, 2023 was $1.45M, a 162% increase year-over-year.
  • Eagle Pharmaceuticals, Inc. Interest Expense for the twelve months ending June 30, 2023 was $6.09M, a 256% increase year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Interest Expense for 2022 was $4.05M, a 147% increase from 2021.
  • Eagle Pharmaceuticals, Inc. annual Interest Expense for 2021 was $1.64M, a 36.6% decline from 2020.
  • Eagle Pharmaceuticals, Inc. annual Interest Expense for 2020 was $2.58M, a 4.06% decline from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $6.09M $1.45M +$896K +162% Apr 1, 2023 Jun 30, 2023 10-Q/A 2023-08-09
Q1 2023 $5.2M $1.52M +$1.15M +314% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $4.05M $1.98M +$1.59M +401% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-23
Q3 2022 $2.46M $1.15M +$751K +190% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $1.71M $552K +$130K +30.8% Apr 1, 2022 Jun 30, 2022 10-Q/A 2023-08-09
Q1 2022 $1.58M $366K -$56K -13.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $1.64M $395K -$18K -4.36% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 $1.65M $396K -$93K -19% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $1.75M $422K -$364K -46.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $2.11M $422K -$467K -52.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $2.58M $413K -$294K -41.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 $2.87M $489K -$139K -22.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $3.01M $786K +$121K +18.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $2.89M $889K +$203K +29.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $2.69M $707K +$90K +14.6% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-08
Q3 2019 $2.6M $628K -$115K -15.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 $2.71M $665K -$36K -5.14% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $2.75M $686K +$11K +1.63% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $2.74M $617K +$75K +13.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-05
Q3 2018 $2.66M $743K +$216K +41% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $2.45M $701K +$661K +1653% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $1.78M $675K +$648K +2400% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $1.14M $542K +$540K +27000% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $596K $527K +$524K +17467% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $72K $40K +$37K +1233% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $35K $27K +$27K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $8K $2K $0 0% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $8K $3K -$2K -40% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $10K $3K $0 0% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $10K $0 -$1K -100% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $11K $2K +$1K +100% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 $10K $5K +$3K +150% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $7K $3K -$2K -40% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $9K $1K $0 0% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $9K $1K +$1K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 $8K $2K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $5K -$11K -68.8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 $1K -$144K -99.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 $0 Oct 1, 2013 Dec 31, 2013 10-K 2017-03-15
Q2 2013 $16K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $145K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.